Evidence map›Paper›PMID 33740155›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2021

Left thoracotomy vs full sternotomy for centrifugal durable LVAD implantation: 1-year outcome comparison post-LVAD and post-heart transplantation.

Camille E Hironaka, Bowei Deng, Masashi Kawabori, Andre C Critsinelis, Yong Zhan, Frederick Y Chen, Amanda Vest, David DeNofrio, Michael S Kiernan, Gregory S Couper

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Left Ventricular Assist Devices: A Primer For the General Cardiologist.Journal of the American Heart Association · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Camille E Hironaka *Tufts University School of Medicine, 145 Harrison Ave., Boston, MA, 02111, USA. Camille.Hironaka@tufts.edu.
Bowei Deng *Tufts University School of Medicine, 145 Harrison Ave., Boston, MA, 02111, USA.
Masashi KawaboriDivision of Cardiac Surgery, Tufts Medical Center, 800 Washington St., South Building, 6th Floor, Boston, MA, 02111, USA. Kawabori.masashi@gmail.com.ORCID http://orcid.org/0000-0002-3580-5664
Andre C CritsinelisDivision of Surgery, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030, USA.
Yong ZhanDivision of Cardiac Surgery, Tufts Medical Center, 800 Washington St., South Building, 6th Floor, Boston, MA, 02111, USA.
Frederick Y ChenDivision of Cardiac Surgery, Tufts Medical Center, 800 Washington St., South Building, 6th Floor, Boston, MA, 02111, USA.
Amanda VestDivision of Cardiology, Tufts Medical Center, 800 Washington St., Boston, MA, 02111, USA.
David DeNofrioDivision of Cardiology, Tufts Medical Center, 800 Washington St., Boston, MA, 02111, USA.
Michael S KiernanDivision of Cardiology, Tufts Medical Center, 800 Washington St., Boston, MA, 02111, USA.
Gregory S CouperDivision of Cardiac Surgery, Tufts Medical Center, 800 Washington St., South Building, 6th Floor, Boston, MA, 02111, USA.
Tufts Medical Center · USTufts University · USBaylor College of Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular assist device (LVAD) implantations have traditionally been approached through a full median sternotomy (FS). Recently, a minimally invasive left thoracotomy (LT) approach has been popularized. This study sought to compare the outcomes of FS and LT patients post-primary LVAD implantation and post-subsequent heart transplant (HT). This was a single-center retrospective study. 83 patients who underwent primary centrifugal durable LVAD implantation from January 2014 to June 2018 were included (FS, n = 41; LT, n = 42). 41 patients had a subsequent HT (FS, n = 19; LT, n = 22). Pre-operative patient demographics, intraoperative variables, post-operative 1-year survival, length of hospital stay, complications, and outcomes for LVAD implantation and following HT were analyzed. Intraoperative data showed that the LT group had a 23.4% longer mean LVAD implant surgical time (p < 0.01). One-year post-LVAD survival was similar between the two groups (p = 0.05). Complication rates, with the exception of the rate of hemorrhagic stroke (p = 0.04) post-LVAD implant were similar. One-year survival post-HT was similar between groups (p = 0.35). Complication rates and mean length of hospital stay were also similar (p = 1.0) post-HT. Our study demonstrated that LT approach does not negatively affect post-LVAD implantation or post-HT outcomes. Further, larger studies may determine more detailed effects of LT approach.

Indexed as

Heart-Assist DevicesHeart FailureHeart TransplantationHumansProsthesis ImplantationRetrospective StudiesSternotomyThoracotomyTreatment OutcomeHeart failureHeart transplantLeft ventricular assist deviceSurgical approach

Identifiers

PMID33740155
OpenAlexW3139237192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.